You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pancreatic ductal adenocarcinoma

Showing 1 - 25 of 6,425
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Boston (other, diagnostic test, combination product)

Not yet recruiting
  • Pancreatic Cancer
  • +4 more
  • Screening Blood Tests
  • +3 more
  • Boston, Massachusetts
  • +1 more
Nov 3, 2023

Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Oligometastatic Disease
  • FOLFIRINOX chemotherapy
  • Baltimore, Maryland
    Johns Hopkins Hospital
Nov 2, 2023

Pancreatic Ductal Adenocarcinoma, Pain, Acute Trial in San Francisco (Ketamine, Meaning and Purpose therapy)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Pain, Acute
  • San Francisco, California
    University of California, San Francisco
Oct 12, 2023

Minimal Residual Disease Using Multi-omics Approach

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
  • Shanghai, China
    Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Nov 29, 2023

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Bio-specimen Collection: Blood
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 21, 2023

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (BXCL701, Pembrolizumab)

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Stereotactic body radiotherapy (SBRT)
  • +4 more
  • New York, New York
    Columbia University Irving Medical Center
Sep 15, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +12 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 30, 2022

Predict Lymphovascular Invasion in Pancreatic Ductal

Recruiting
  • Predictive Cancer Model
  • Pancreas Cancer
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Aug 10, 2023

    PDAC - Pancreatic Ductal Adenocarcinoma Trial in Nijmegen (CT Perfusion)

    Recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • CT Perfusion
    • Nijmegen, Gelderland, Netherlands
      Radboud University Medical Hospital
    Dec 20, 2022

    Adenocarcinoma, Pancreatic Ductal Trial in New York (Autogene cevumeran, Atezolizumab, mFOLFIRINOX)

    Recruiting
    • Adenocarcinoma, Pancreatic Ductal
    • Autogene cevumeran
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 21, 2023

    Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor Trial in Petaling Jaya (Dendritic cell + Cytokine-induced killer cell

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Advanced Solid Tumor
    • Dendritic cell + Cytokine-induced killer cell (DC+CIK) immunotherapy
    • Tegafur Only Product
    • Petaling Jaya, Kuala Lumpur, Malaysia
      Clinical Oncology Department, Ummc
    Jul 12, 2023

    Carcinoma, Pancreatic Ductal Trial in Trondheim (SonoVue, Chemotherapy)

    Completed
    • Carcinoma, Pancreatic Ductal
    • Trondheim, Norway
      Department of Radiology, St Olavs Hospital
    Jan 17, 2023

    3D Bioprinting for Personalized Treatment in Pancreatic Ductal

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
      • Beijing, Beijing, China
      • +1 more
      Jul 12, 2023

      Pancreatic Ductal Adenocarcinoma

      Recruiting
      • PDAC - Pancreatic Ductal Adenocarcinoma
      • Pancreatic Cancer
      • Breath test
      • Collection of matched samples of breath, biofluids and pancreatic tissue
      • London, United Kingdom
        Imperial College Healthcare NHS Trust
      Feb 3, 2023

      Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

      Not yet recruiting
      • Metastatic Pancreatic Cancer
      • Washington, District of Columbia
        Lombardi Comprehensive Cancer Center, Georgetown University
      Apr 11, 2023

      Pancreatic Ductal Adenocarcinoma Trial (NP137, Oxaliplatin, Irinotecan)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • (no location specified)
      Sep 23, 2022

      Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Refractory Non-Small Cell Lung Cancer
      • Washington, District of Columbia
        Georgetown Lombardi Comprehensive Cancer Center
      Sep 1, 2023

      Myosteatosis and Creatinine-to-cystatin C Ratio in Pancreatic

      Recruiting
      • Skeletal Muscle Radiodensity
      • +3 more
        • Qingdao, Shandong, China
          the Affiliated Hospital of Qingdao University
        Nov 6, 2022

        Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

        Not yet recruiting
        • Metastatic Pancreatic Cancer
        • Durvalumab
        • Rintatolimod
        • Rotterdam, Zuid-Holland, Netherlands
          Erasmus MC
        Jun 23, 2023

        Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

        Recruiting
        • Metastatic Pancreatic Ductal Adenocarcinoma
        • Stage IV Pancreatic Cancer AJCC v8
        • Autologous Mesothelin-specific TCR-T Cells
        • +2 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Jan 31, 2023

        Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (Eryaspase,

        Active, not recruiting
        • Locally Advanced Pancreatic Ductal Adenocarcinoma
        • Metastatic Pancreatic Ductal Adenocarcinoma
        • Washington, District of Columbia
          Georgetown Lombardi Comprehensive Cancer Center
        Aug 3, 2022

        Healthy Volunteers, Pancreatic Ductal Adenocarcinoma Trial (RAD301 ([68Ga]-Trivehexin))

        Not yet recruiting
        • Healthy Volunteers
        • Pancreatic Ductal Adenocarcinoma
        • RAD301 ([68Ga]-Trivehexin)
        • (no location specified)
        Mar 22, 2023

        Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Indianapolis (Lonsurf, Gemcitabine, Nab-Paclitaxel)

        Active, not recruiting
        • Pancreatic Cancer
        • Pancreatic Ductal Adenocarcinoma
        • Indianapolis, Indiana
          Indiana University Melvin & Bren Simon Cancer Center
        Nov 29, 2022

        Novel MRI Techniques for Pancreatic Cancer

        Withdrawn
        • Pancreatic Ductal Adenocarcinoma
        • MRI
        • (no location specified)
        Jul 19, 2022